158 related articles for article (PubMed ID: 36338432)
21. The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants.
Chen Y; Chen L; Yin S; Tao Y; Zhu L; Tong X; Mao M; Li M; Wan Y; Ni J; Ji X; Dong X; Li J; Huang R; Shen Y; Shen H; Bao C; Wu C
Emerg Microbes Infect; 2022 Dec; 11(1):1524-1536. PubMed ID: 35608053
[TBL] [Abstract][Full Text] [Related]
22. Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant.
Zuo F; Abolhassani H; Du L; Piralla A; Bertoglio F; de Campos-Mata L; Wan H; Schubert M; Cassaniti I; Wang Y; Sammartino JC; Sun R; Vlachiotis S; Bergami F; Kumagai-Braesch M; Andréll J; Zhang Z; Xue Y; Wenzel EV; Calzolai L; Varani L; Rezaei N; Chavoshzadeh Z; Baldanti F; Hust M; Hammarström L; Marcotte H; Pan-Hammarström Q
Nat Commun; 2022 May; 13(1):2670. PubMed ID: 35562366
[TBL] [Abstract][Full Text] [Related]
23. Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination.
Suntronwong N; Assawakosri S; Kanokudom S; Yorsaeng R; Auphimai C; Thongmee T; Vichaiwattana P; Duangchinda T; Chantima W; Pakchotanon P; Chansaenroj J; Nilyanimit P; Srimuan D; Thatsanatorn T; Sudhinaraset N; Wanlapakorn N; Mongkolsapaya J; Poovorawan Y
Diagnostics (Basel); 2022 Jul; 12(8):. PubMed ID: 35892491
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and Effectiveness of Primary and Booster Vaccine Combination Strategies during Periods of SARS-CoV-2 Delta and Omicron Variants.
Moghnieh R; El Hajj C; Abdallah D; Jbeily N; Bizri AR; Sayegh MH
Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298460
[TBL] [Abstract][Full Text] [Related]
25. Durability and Immunogenicity of Neutralizing Antibodies Response Against Omicron Variants After Three Doses of Subunit SARS-CoV-2 Vaccine MVC-COV1901: An Extension to an Open-Label, Dose-Escalation Phase 1 Study.
Hsieh SM; Chang SC; Cheng HY; Shih SR; Lien CE
Infect Dis Ther; 2022 Aug; 11(4):1493-1504. PubMed ID: 35579840
[TBL] [Abstract][Full Text] [Related]
26. Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern.
Shi J; Wang G; Zheng J; Verma AK; Guan X; Malisheni MM; Geng Q; Li F; Perlman S; Du L
NPJ Vaccines; 2022 Dec; 7(1):169. PubMed ID: 36535987
[TBL] [Abstract][Full Text] [Related]
27. Quantitative and Qualitative Difference in Antibody Response against Omicron and Ancestral SARS-CoV-2 after Third and Fourth Vaccination.
Hein S; Mhedhbi I; Zahn T; Sabino C; Benz NI; Husria Y; Renelt PM; Braun F; Oberle D; Maier TJ; Hildt C; Hildt E
Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632552
[TBL] [Abstract][Full Text] [Related]
28. Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5-included SARS-CoV-2 variants than homologous vaccination of mRNA vaccine.
Peng D; Zhao T; Hong W; Fu M; He C; Chen L; Ren W; Lei H; Yang J; Alu A; Ni Y; Liu J; Li J; Wang W; Shen G; Zhao Z; Yang L; Yang J; Wang Z; Tanaka Y; Lu G; Song X; Wei X
MedComm (2020); 2023 Apr; 4(2):e238. PubMed ID: 36911160
[TBL] [Abstract][Full Text] [Related]
29. The impact of CoronaVac on the neutralization breadth and magnitude of the antibody response to SARS-CoV-2 viruses.
Zhang L; Chen H; Yang S; Zhao Y; Shen X; He X; Ye H; Wang D; Lou J; Wang Y; Wu S
Front Immunol; 2022; 13():990071. PubMed ID: 36203574
[TBL] [Abstract][Full Text] [Related]
30. A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants.
Lee IJ; Sun CP; Wu PY; Lan YH; Wang IH; Liu WC; Yuan JP; Chang YW; Tseng SC; Tsung SI; Chou YC; Kumari M; Lin YS; Chen HF; Chen TY; Lin CC; Chiu CW; Hsieh CH; Chuang CY; Cheng CM; Lin HT; Chen WY; Hsu FF; Hong MH; Liao CC; Chang CS; Liang JJ; Ma HH; Chiang MT; Liao HN; Ko HY; Chen LY; Ko YA; Yu PY; Yang TJ; Chiang PC; Hsu ST; Lin YL; Lee CC; Wu HC; Tao MH
J Biomed Sci; 2022 Jul; 29(1):49. PubMed ID: 35799178
[TBL] [Abstract][Full Text] [Related]
31. Sequential immunizations confer cross-protection against variants of SARS-CoV-2, including Omicron in Rhesus macaques.
Deng W; Lv Q; Li F; Liu J; Song Z; Qi F; Wei Q; Yu P; Liu M; Zhou S; Zhang Y; Gao H; Wang N; Jia Z; Gao K; Liu J; Xiao C; Shang H; Wang X; Bao L; Qin C
Signal Transduct Target Ther; 2022 Apr; 7(1):124. PubMed ID: 35436986
[TBL] [Abstract][Full Text] [Related]
32. Comparative characterization of antibody responses induced by Ad5-vectored spike proteins of emerging SARS-CoV-2 VOCs.
Wang B; Xu J; Wu S; Zhang Z; Zhao Z; Zhang J; Fu L; Zai X; Wang Y; Zhang G; Chen Z; Chen Y; Sun H; Song X; Zhang J; Zhu L; Hou L; Chen W
Signal Transduct Target Ther; 2022 Jul; 7(1):257. PubMed ID: 35906201
[TBL] [Abstract][Full Text] [Related]
33. Neutralization Activity against SARS-CoV-2 Variants after Booster Vaccination in Populations without COVID-19: A Meta-Analysis.
Cheng H; Peng Z; Si S; Alifu X; Zhou H; Chi P; Zhuang Y; Mo M; Yu Y
Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891263
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines.
He X; Su J; Ma Y; Zhang W; Tang S
Front Immunol; 2022; 13():945930. PubMed ID: 36090988
[TBL] [Abstract][Full Text] [Related]
35. Homologous and heterologous booster vaccinations of S-268019-b, a recombinant S protein-based vaccine with a squalene-based adjuvant, enhance neutralization breadth against SARS-CoV-2 Omicron subvariants in cynomolgus macaques.
Hashimoto M; Aoe S; Kawazu Y; Seki NM; Hashimoto K; Yoshihara K; Homma T; Sonoyama T; Omoto S
Vaccine; 2022 Dec; 40(52):7520-7525. PubMed ID: 36372670
[TBL] [Abstract][Full Text] [Related]
36. Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization.
Pradenas E; Marfil S; Urrea V; Trigueros M; Pidkova T; Pons-Grífols A; Ortiz R; Rovirosa C; Tarrés-Freixas F; Aguilar-Gurrieri C; Toledo R; Chamorro A; Noguera-Julian M; Mateu L; Blanco I; Grau E; Massanella M; Carrillo J; Clotet B; Trinité B; Blanco J
iScience; 2023 Apr; 26(4):106457. PubMed ID: 36999095
[TBL] [Abstract][Full Text] [Related]
37. Sequential reinfection with Omicron variants elicits broader neutralizing antibody profiles in booster vaccinees and reduces the duration of viral shedding.
Wei D; Yu X; Li Y; Chen Y; Chen E; Wang Y; Yang Z; Zhang X
J Med Virol; 2023 Oct; 95(10):e29151. PubMed ID: 37805829
[TBL] [Abstract][Full Text] [Related]
38. Immunogenicity of BNT162b2 Vaccination against SARS-CoV-2 Omicron Variant and Attitudes toward a COVID-19 Booster Dose among Healthy Thai Adolescents.
Assavavongwaikit P; Chantasrisawad N; Himananto O; Phasomsap C; Klawaja P; Cartledge S; Nadsasarn R; Jupimai T; Kawichai S; Anugulruengkitt S; Puthanakit T; On Behalf Of The Study Team
Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891264
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
40. Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine.
Liwsrisakun C; Pata S; Laopajon W; Takheaw N; Chaiwong W; Inchai J; Pothirat C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A; Tajarernmuang P; Niyatiwatchanchai N; Trongtrakul K; Chuensirikulchai K; Kasinrerk W
Immun Ageing; 2022 May; 19(1):24. PubMed ID: 35610643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
